Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The French National Authority for Health (HAS) published new set of decisions about add-on reimbursement for medical devices in December

24 Jan 2018

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 12 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December.

Four decisions were released for respiratory prostheses for total laryngectomy with or without phonatory implants:

Three decisions were issued for cardiovascular devices:

  • JARVIK 2000,  ventricular assist device (administrative amendment)
  • CoreValve Evolut PRO, transcutaneous bioprosthetic aortic heart valve (application for registration, approved)
  • GLIDELIGHT, laser sheath for extraction of stimulation probes and cardiac defibrillation (application for registration, approved)

Two decisions were published about mandibular advancement devices:

  • TALI, (renewal of registration, approved)
  • TWICARE, (application for registration, rejected due to insufficient expected benefit (AS))

Three decisions consider other devices:

  • ACRYSOF IQ TORIC, intraocular monofocal toric lens (application for registration, approved)
  • HOMEFILL II, home oxygen system (renewal of registration, approved)
  • PHYSIOTULLE, wound dressing (renewal of registration, approved)

See list of decisions in French here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.